Intrinsic antiviral immunity drives neurodegeneration in Alzheimer disease.
Level V
Where this comes from
- Record sourced from PubMed, PMID 32149728.
- Also identified by DOI 10.1172/JCI135906 and PMC identifier 7108882.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
β-Amyloid aggregates found in brain plaques are viewed as triggers of cytotoxicity and neuroinflammation in Alzheimer disease (AD). However, the main β-amyloid (Aβ) species and what imbues the aggregates with such toxic potential are still not yet understood. In this issue of the JCI, Roy et al. show that Aβ complexed with nucleic acids triggers an antiviral type I interferon response in neuroglia, resulting in complement-mediated synapse elimination in AD models. These findings identify a putative endogenous immune signaling axis that drives neurodegeneration in AD and has strong implications for the development of precise therapeutic strategies.
Medical subject headings
- Alzheimer Disease
- Interferon Type I